CAL
RCUS icon

Capital Advisors Ltd’s Arcus Biosciences RCUS Stock Holding History

Capital Advisors Ltd’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Hold
1
– – ﹤0.01% 1548
2026
Q1 		$0 Hold
1
– – ﹤0.01% 1559
2025
Q4 		$0 Hold
1
– – ﹤0.01% 1533
2025
Q3 		$0 Hold
1
– – ﹤0.01% 1522
2025
Q2 		$0 Buy
+1
New +$9 ﹤0.01% 1584

Other funds holding RCUS

TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
SAM
Seelaus Asset Management Chatham, New Jersey $142M AUM 48.54% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

Capital Advisors Ltd's RCUS Position: Q2 2026 in Review

Capital Advisors Ltd held its Arcus Biosciences (RCUS) position steady in Q2 2026 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1548.

Capital Advisors Ltd first reported a position in RCUS in Q2 2025 and has held it in 5 quarters since. 23 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Capital Advisors Ltd held 1 share of Arcus Biosciences worth $0 as of Q2 2026.
  • Capital Advisors Ltd left its Arcus Biosciences share count unchanged in Q2 2026.
  • Arcus Biosciences made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #1548 holding.
  • Capital Advisors Ltd first reported a position in Arcus Biosciences in Q2 2025 and has held it in 5 quarters since.
  • 23 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.